See more : Delta Corp Limited (DELTACORP.NS) Income Statement Analysis – Financial Results
Complete financial analysis of E. I. du Pont de Nemours and Company (CTA-PB) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of E. I. du Pont de Nemours and Company, a leading company in the Agricultural Inputs industry within the Basic Materials sector.
- Sipef NV (0JSU.L) Income Statement Analysis – Financial Results
- Apollo Healthcare Corp. (AHC.TO) Income Statement Analysis – Financial Results
- Financial 15 Split Corp (FTN-PA.TO) Income Statement Analysis – Financial Results
- Singularity Future Technology Ltd. (SGLY) Income Statement Analysis – Financial Results
- Canadian Utilities Limited (CDUUF) Income Statement Analysis – Financial Results
E. I. du Pont de Nemours and Company (CTA-PB)
About E. I. du Pont de Nemours and Company
E. I. du Pont de Nemours and Company provides seeds and crop protection products for the agriculture industry in the United States, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. It operates through Seed and Crop Protection segments. The Seed segment develops and supplies advanced germplasm and traits that produce yield for farms; offers corn, soybean, and other oil seeds; trait technologies that enhance resistance to weather, disease, insects, and herbicides, which is used to control weeds. It also enhances food and nutritional characteristics; and digital solutions that assist farmer decision-making with a view to optimizing product selection and yield. The Crop Protection segment serves the agricultural input industry with products that protect against weeds, insects and other pests, and diseases, as well as enhance overall crop health above and below ground via nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers and pasture, and range management herbicides. In addition, it offers its products under the Pioneer, Brevant, Dairyland Seed, Hoegemeyer, Nutech, Seed Consultants, AgVenture, Alforex, PhytoGen, Pannar, VP Maxx, HPT, G2, Supreme EX, XL, Power Plus, ENLIST E3, ENLIST, EXZACT, HERCULEX, Leptra, POWERCORE, Optimum, AcreMax, REFUGE ADVANCED, SMARTSTAX, NEXERA, Omega-9 Oils, AQUAmax, Plenish, ExpressSun, Protector, Pioneer MAXIMUS, Qrome, Clearfield, PROPOUND, Conkesta, Conkesta E3, WideStrike, LumiGEN, LUMIDERM, LUMIVIA, LUMIALZA, GRANULAR, ACREVALUE, Granular, and Insights brand names. The company was founded in 1802 and is headquartered in Wilmington, Delaware. E. I. du Pont de Nemours and Company is a subsidiary of Corteva, Inc.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2007 | 2005 | 2001 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 17.23B | 17.46B | 15.66B | 14.22B | 13.85B | 14.29B | 14.24B | 14.04B | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 9.92B | 10.44B | 9.22B | 8.51B | 8.58B | 8.52B | 8.40B | 8.39B | 0.00 | 0.00 | 0.00 |
| Gross Profit | 7.31B | 7.02B | 6.44B | 5.71B | 5.27B | 5.77B | 5.84B | 5.65B | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 42.41% | 40.21% | 41.11% | 40.16% | 38.07% | 40.36% | 41.00% | 40.24% | 0.00% | 0.00% | 0.00% |
| Research & Development | 1.34B | 1.22B | 1.19B | 1.14B | 1.15B | 1.43B | 1.51B | 1.51B | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 3.17B | 0.00 | 3.04B | 3.07B | 2.90B | 2.97B | 2.94B | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 3.18B | 3.17B | 3.21B | 3.04B | 3.07B | 2.90B | 2.97B | 2.94B | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | 702.00M | 722.00M | 682.00M | 475.00M | 142.00M | 1.17B | 320.00M | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 4.51B | 5.09B | 5.12B | 4.87B | 4.69B | 4.48B | 5.65B | 4.76B | 0.00 | 0.00 | 0.00 |
| Cost & Expenses | 15.12B | 15.53B | 14.34B | 13.37B | 13.26B | 13.00B | 14.05B | 13.16B | 0.00 | 0.00 | 0.00 |
| Interest Income | 283.00M | 124.00M | 77.00M | 56.00M | 59.00M | 80.00M | 0.00 | 102.00M | 0.00 | 0.00 | 0.00 |
| Interest Expense | 233.00M | 79.00M | 30.00M | 45.00M | 136.00M | 76.00M | 74.00M | 101.00M | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 1.21B | 1.22B | 1.24B | 1.18B | 1.00B | 909.00M | 1.56B | 1.26B | 0.00 | 0.00 | 0.00 |
| EBITDA | 2.54B | 2.73B | 3.62B | 1.90B | 820.00M | -5.56B | 443.00M | 4.35B | 0.00 | 0.00 | 0.00 |
| EBITDA Ratio | 14.73% | 17.71% | 24.96% | 15.70% | 9.20% | 28.56% | 3.22% | 8.07% | 0.00% | 0.00% | 0.00% |
| Operating Income | 2.11B | 1.87B | 2.67B | 1.06B | 799.00M | 1.29B | 188.00M | 886.00M | 0.00 | 0.00 | 0.00 |
| Operating Income Ratio | 12.25% | 10.70% | 17.02% | 7.42% | 5.77% | 9.03% | 1.32% | 6.31% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -1.02B | -442.00M | -319.00M | -380.00M | -1.01B | -6.36B | 17.00M | -628.00M | 0.00 | 0.00 | 0.00 |
| Income Before Tax | 1.09B | 1.43B | 2.35B | 675.00M | -316.00M | -4.55B | -374.00M | 258.00M | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | 6.35% | 8.17% | 14.99% | 4.75% | -2.28% | -31.88% | -2.63% | 1.84% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 152.00M | 210.00M | 524.00M | -81.00M | -46.00M | 408.00M | -2.94B | -270.00M | 0.00 | 0.00 | 0.00 |
| Net Income | 735.00M | 1.15B | 1.76B | 681.00M | -270.00M | -4.99B | 2.53B | 503.00M | 0.00 | 0.00 | 0.00 |
| Net Income Ratio | 4.27% | 6.57% | 11.24% | 4.79% | -1.95% | -34.93% | 17.79% | 3.58% | 0.00% | 0.00% | 0.00% |
| EPS | 0.85 | 1.32 | 2.39 | 0.91 | -1.28 | -5.75 | 2.92 | 0.58 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.85 | 1.32 | 2.37 | 0.91 | -1.28 | -5.75 | 2.92 | 0.58 | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 867.81M | 867.81M | 0.00 | 0.00 | 0.00 | 867.81M | 867.81M | 867.81M | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out (Dil) | 867.81M | 867.81M | 0.00 | 0.00 | 0.00 | 867.81M | 867.81M | 867.81M | 0.00 | 0.00 | 0.00 |
Source: https://incomestatements.info
Category: Stock Reports